Skip to content

Immunovant, Inc. IMVT Business Segments — Other general and administrative

Similar metrics at other companies

Enphase Energy logo
ENPHReportable Segment — Other general and administrative
$20.35M-4.0%
Booking Holdings Inc. logo
BKNGReportable Segment — Other General Expense
$40M-37.5%
Rollins logo
ROLReportable Segment — Other sales, general and administrative
$58.33M+13.5%
Silicon Laboratories logo
SLABReportable Segment — Other selling, general and administrative expenses
$41.71M+51.5%
Chewy logo
CHWYReportable Segment — Other selling, general, and administrative expenses
$208.5M+4.9%
Tractor Supply Company logo
TSCOReportable Segment — Other segment expenses
$416.23M+4.9%

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$7.26B+74.2%
Enterprise value$6.35B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0.0×
Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherGeneralAndAdministrativeExpense.

The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunovant, Inc.'s business segments — other general and administrative.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immunovant, Inc.'s business segments — other general and administrative?
Immunovant, Inc. (IMVT) reported business segments — other general and administrative of $7.14M in Q1 2026.
How has Immunovant, Inc.'s business segments — other general and administrative changed year-over-year?
Immunovant, Inc.'s business segments — other general and administrative decreased by 34.4% year-over-year, from $10.88M to $7.14M.
What is the long-term trend for Immunovant, Inc.'s business segments — other general and administrative?
Over 3 years (2023 to 2026), Immunovant, Inc.'s business segments — other general and administrative has grown at a 11.0% compound annual growth rate (CAGR), from $20.11M to $27.51M.
What does business segments — other general and administrative mean?
Captures non-personnel administrative expenses such as facility costs, professional fees, insurance, and general office overhead for the segment. These costs represent the necessary operational expenditures to maintain business functions outside of direct R&D or personnel compensation. Tracking this helps assess the company's ability to control indirect operating costs.